November MIMS Update

We look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products  Andexanet alfa (Andexxa) is a recombinant form of human factor Xa (FXa) protein that has been modified to lack FXa enzymatic activity. The active site serine was substituted with alanine, rendering the molecule unable to